Novel compounds
AssigneeSmithKline Beecham Corporation
InventorsSteven Mark Bromidge, Francis David King, Paul Adrian Wyman
Life of this patent
Estimating the term…
Loading patent…
AssigneeSmithKline Beecham Corporation
InventorsSteven Mark Bromidge, Francis David King, Paul Adrian Wyman
Estimating the term…
A compound of formula (I) or a pharmaceutically acceptable salt thereof: 1 wherein: P is phenyl, naphthyl, thiophene or benzothiophene; A is a single bond, a C1-6alkylene or a C1-6alkenylene group; R1 is halogen, C1-6alkyl, optionally substituted by one or more halogen atoms, C3-6cycloalkyl, C1-6alkoxy, OCF3, hydroxy, hydroxyC1-6alkyl, hydroxyC1-6alkoxy, C1-6alkoxyC1-6alkoxy, C1-6alkanoyl, nitro, amino, C1-6alkylamino, di C1-6alkylamino or cyano; or R1 is phenyl]; n is 0,1, 2, 3, 4, 5 or 6: R2 is C1-6 alkyl phenyl-C1-6alkyl or naphthyl-C1-6 alkyl; R3 is a group R5 or together with R5 forms a group (CH2)2O or (CH2)3O; R4 is a piperazine ring optionally substituted by C1-6 alkyl; and R5 is hydrogen, halogen, C1-6alkyl, C3-6cycloalkyl, C1-6alkoxy, hydroxy, hydroxyC1-6alkyl, hydroxyC1-6alkoxy, C1-6alkoxyC1-6alkoxy, C1-6alkanoyl, nitro, trifluoromethyl, cyano phenyl or naphthyl, is provided. The present compounds are useful as 5-HT6 receptor modulators..
A compound of formula (I) or a salt thereof:
A process for the preparation of a compound of formula (I) or a salt thereof
Dependencies are inferred from the claim text.